Diagnostic standards in the pathology of inflammatory bowel disease

Digestive Diseases

Volumn 27, Issue 4, 2009, Pages 576-583

  Loddenkemper, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Carcinoma in inflammatory bowel disease; Dysplasia associated lesion or mass; Inflammatory bowel disease, diagnostic standards in pathology; Inflammatory bowel disease, differential diagnosis; Intraepithelial neoplasia

Indexed keywords

BETA CATENIN; PROTEIN P53;

ADENOMA LIKE MASS; AWARENESS; CARCINOGENESIS; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLON RESECTION; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DYSPLASIA ASSOCIATED LESION OR MASS; HUMAN; IATROGENIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTRAEPITHELIAL NEOPLASIA; LYMPHOPROLIFERATIVE DISEASE; NEOPLASM; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; TUMOR BIOPSY; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; ULCERATIVE COLITIS;

COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; IATROGENIC DISEASE; INFLAMMATORY BOWEL DISEASES; LYMPHOPROLIFERATIVE DISORDERS;

EID: 70449482735     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000233301     Document Type: Review

References (16)

1. Fenoglio-Preiser CM: Gastrointestinal Pathology: An Atlas and Text, ed 3. Philadelphia, Lippincott Williams & Wilkins, 2008.
2. Schneider T, Ulrichs T, Loddenkemper C, Lode H, Zeitz M, Scherubl H: Intestinal tuberculosis: a clinical and diagnostic challenge. Dtsch Med Wochenschr 2004; 129: 1747-1752.
3. Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D: 100th anniversary of Whipple's disease: new aspects on pathogenesis and treatment of this enigmatic multisystemic infection. Lancet Infect Dis 2008; 8: 179-190.
4. Karcher H, Loddenkemper C, Zeitz M, Schneider T: Intestinal schistosomiasis in a traveller returning from Rwanda and Burundi. Int J Colorectal Dis 2008; 23: 1021-1022.
5. Schellhaas E, Loddenkemper C, Schmittel A, Buhr HJ, Pohlen U: Bowel perforation in non-small cell lung cancer after bevacizumab therapy. Invest New Drugs 2009; 27: 184-187.
6. Hamilton SR, Aaltonen LA: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon, ARC Press, 2000.
7. Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M: Clinical practice guideline on diagnosis and treatment of Crohn's disease. Z Gastroenterol 2008; 46: 1094-1146.
8. Blackstone MO, Riddell RH, Rogers BH, Levin B: Dysplasia-associated lesion or mass detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80: 366-374.
9. Engelsgjerd M, Farraye FA, Odze RD: Polypectomy may be adequate treatment for adenoma- like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999; 117: 1288-1294.
10. Walsh SV, Loda M, Torres CM, Antonioli D, Odze RD: P53 and -catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol 1999; 23: 963-969.
11. Heimann TM, Oh SC, Martinelli G, Szporn A, Luppescu N, Lembo CA, Kurtz RJ, Fasy TM, Greenstein AJ: Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators. Am J Surg 1992; 164: 13-17.
12. Aust DE, Terdiman JP, Willenbucher RF, Chang CG, Molinaro-Clark A, Baretton GB, Loehrs U, Waldman FM: The APC/ -catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 2002; 94: 1421-1427.
13. Loddenkemper C, Keller S, Hanski ML, Cao M, Jahreis G, Stein H, Zeitz M, Hanski C: Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid. Int J Cancer 2006; 118: 2750-2757.
14. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC, 2008.
15. Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M: Hepatosplenic T-cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 44: 265-267.
16. Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J: Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 2007; 13: 1024-1030.